Global Rho(D) Immune Globulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Rho(D) Immune Globulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Rho(D) Immune Globulin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rho(D) Immune Globulin market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Government Institution and Private Sector are the major drivers for the industry.
Rho(D) Immune Globulin, also known as anti-Rh factor immunoglobulin, is a biological product used to prevent Rh hemolytic disease of the newborn in cases where an Rh-negative mother is carrying an Rh-positive fetus. In the market, driven by advancements in medical technology and awareness, there is a steady growth in demand for Rho(D) immune globulin. Currently, the product finds extensive application in the fields of prenatal care and obstetrics, particularly in high-risk pregnancies to prevent Rh hemolytic disease. With ongoing advancements in biologic manufacturing techniques, the future development of Rho(D) immune globulin might focus on refinement to enhance efficacy and reduce side effects, catering to the continually expanding market needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rho(D) Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
CSL Behring
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics
Segment by Type
5 ml
10 ml
Government Institution
Private Sector
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Rho(D) Immune Globulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rho(D) Immune Globulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rho(D) Immune Globulin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rho(D) Immune Globulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rho(D) Immune Globulin introduction, etc. Rho(D) Immune Globulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rho(D) Immune Globulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Rho(D) Immune Globulin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rho(D) Immune Globulin market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Government Institution and Private Sector are the major drivers for the industry.
Rho(D) Immune Globulin, also known as anti-Rh factor immunoglobulin, is a biological product used to prevent Rh hemolytic disease of the newborn in cases where an Rh-negative mother is carrying an Rh-positive fetus. In the market, driven by advancements in medical technology and awareness, there is a steady growth in demand for Rho(D) immune globulin. Currently, the product finds extensive application in the fields of prenatal care and obstetrics, particularly in high-risk pregnancies to prevent Rh hemolytic disease. With ongoing advancements in biologic manufacturing techniques, the future development of Rho(D) immune globulin might focus on refinement to enhance efficacy and reduce side effects, catering to the continually expanding market needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rho(D) Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CSL Behring
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics
Segment by Type
5 ml
10 ml
Segment by Application
Government Institution
Private Sector
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Rho(D) Immune Globulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rho(D) Immune Globulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rho(D) Immune Globulin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rho(D) Immune Globulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rho(D) Immune Globulin introduction, etc. Rho(D) Immune Globulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rho(D) Immune Globulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices